SE8604950D0 - Dementia-improving and therapeutic agents - Google Patents

Dementia-improving and therapeutic agents

Info

Publication number
SE8604950D0
SE8604950D0 SE8604950A SE8604950A SE8604950D0 SE 8604950 D0 SE8604950 D0 SE 8604950D0 SE 8604950 A SE8604950 A SE 8604950A SE 8604950 A SE8604950 A SE 8604950A SE 8604950 D0 SE8604950 D0 SE 8604950D0
Authority
SE
Sweden
Prior art keywords
therapeutic agents
improving
sulfonic acid
acid residue
same
Prior art date
Application number
SE8604950A
Other languages
English (en)
Other versions
SE8604950L (sv
SE469059B (sv
Inventor
F Kuzuya
H Endo
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of SE8604950D0 publication Critical patent/SE8604950D0/sv
Publication of SE8604950L publication Critical patent/SE8604950L/sv
Publication of SE469059B publication Critical patent/SE469059B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8604950A 1985-11-19 1986-11-19 Anvaendning av acyloxialkanoylkolinsalt foer framstaellning av laekemedel foer behandling av neuropsykiatriska symtom som aatfoeljer demens SE469059B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60257881A JPH0733332B2 (ja) 1985-11-19 1985-11-19 痴呆症状改善・治療剤

Publications (3)

Publication Number Publication Date
SE8604950D0 true SE8604950D0 (sv) 1986-11-19
SE8604950L SE8604950L (sv) 1987-05-20
SE469059B SE469059B (sv) 1993-05-10

Family

ID=17312478

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8604950A SE469059B (sv) 1985-11-19 1986-11-19 Anvaendning av acyloxialkanoylkolinsalt foer framstaellning av laekemedel foer behandling av neuropsykiatriska symtom som aatfoeljer demens

Country Status (12)

Country Link
US (1) US4713376A (sv)
JP (1) JPH0733332B2 (sv)
AU (1) AU590640B2 (sv)
CA (1) CA1278519C (sv)
CH (1) CH668184A5 (sv)
DE (1) DE3639378A1 (sv)
DK (1) DK169607B1 (sv)
FR (1) FR2590170B1 (sv)
GB (1) GB2184653B (sv)
IT (1) IT1200041B (sv)
NL (1) NL8602933A (sv)
SE (1) SE469059B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040208875A1 (en) * 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
AU754679B2 (en) * 1998-02-13 2002-11-21 Dr. Willmar Schwabe Gmbh & Co Use of hyperforin and hyperforin-containing extracts in the treatment and prophylaxis of dementing diseases
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
WO2005019157A1 (en) * 2003-08-15 2005-03-03 Patel Hasmukh B Choline esters useful for the treatment of cognitive dysfunctions and enhancement of memory, learning and cognition
US7803842B2 (en) * 2004-06-08 2010-09-28 Hass Patel Choline esters useful for the treatment of cognitive dysfunctions and enhancement of memory, learning and cognition
CA2586111A1 (en) * 2004-11-12 2006-06-08 Neurochem (International) Limited Methods and fluorinated compositions for treating amyloid-related diseases
CA2586334A1 (en) * 2004-11-16 2006-06-08 Neurochem (International) Limited Compounds for the treatment of cns and amyloid associated diseases
AU2005326962A1 (en) 2004-12-22 2006-08-17 Bellus Health (International) Limited Methods and compositions for treating amyloid-related diseases
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
DE602006016990D1 (de) * 2005-12-22 2010-10-28 Bellus Health Int Ltd Behandlung von diabetischer nephropathie
WO2009019534A2 (en) 2006-10-12 2009-02-12 Bellus Health (International) Limited Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
EP2120905A1 (en) * 2006-12-22 2009-11-25 BELLUS Health (International) Limited Methods, compounds, and compositions for treating metabolic disorders and diabetes
MX2009008364A (es) * 2007-02-07 2009-08-20 Astrazeneca Ab Sal de napadisilato de un antagonista m3 muscarinico.
TW201115409A (en) * 2009-10-29 2011-05-01 Hannspree Inc A mouse capable of generating vapor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1336350A (en) * 1970-12-28 1973-11-07 Toyama Chemical Co Ltd Choline derivatives and process for producing the same
DE2425983C3 (de) * 1973-06-12 1978-09-14 Toyama Chemical Co. Ltd., Tokio Sulfonsäuresalze von Acylcholinen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzung
JPS5221490A (en) * 1975-08-12 1977-02-18 Mitsubishi Rayon Co Printing method
JPS592904B2 (ja) * 1976-09-18 1984-01-21 日本ビクター株式会社 デイスプレイ装置
JPS551251A (en) * 1978-06-20 1980-01-08 Yamaha Motor Co Ltd Brake pedal for motorcycle
JPS58180463A (ja) * 1982-04-19 1983-10-21 Toyama Chem Co Ltd ビスコリンジスルホナ−ト類の製造法

Also Published As

Publication number Publication date
IT8648670A0 (it) 1986-11-19
FR2590170B1 (fr) 1990-08-24
CA1278519C (en) 1991-01-02
DE3639378A1 (de) 1987-05-27
GB2184653A (en) 1987-07-01
DK550586A (da) 1987-05-20
IT1200041B (it) 1989-01-05
AU6530286A (en) 1987-05-21
JPS62120317A (ja) 1987-06-01
US4713376A (en) 1987-12-15
DK169607B1 (da) 1994-12-27
JPH0733332B2 (ja) 1995-04-12
CH668184A5 (de) 1988-12-15
DE3639378C2 (sv) 1990-05-10
GB8627484D0 (en) 1986-12-17
NL8602933A (nl) 1987-06-16
FR2590170A1 (fr) 1987-05-22
AU590640B2 (en) 1989-11-09
DK550586D0 (da) 1986-11-18
SE8604950L (sv) 1987-05-20
SE469059B (sv) 1993-05-10
GB2184653B (en) 1989-11-15

Similar Documents

Publication Publication Date Title
SE8604950D0 (sv) Dementia-improving and therapeutic agents
DE3271269D1 (en) Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
SE8404019L (sv) Oftalmiska antiinflammatoriska medel
ES2000185A6 (es) Procedimiento para preparar derivados de acidos piridoncaboxilicos
ES2062443T3 (es) Nuevos derivados peptidicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2037665T3 (es) Procedimiento para la preparacion de compuestos heterociclicos que contienen n.
DK288686A (da) Farmaceutiske praeparater
ES508343A0 (es) "procedimiento para la preparacion de nuevas pirimido (5,4-d) pirimidinas trisustituidas".
ZA816259B (en) 2-(1,4-benzodioxan-2-ylalkyl)imidazoles useful as antidepressants
SE7704616L (sv) Sett att framstella nya 11-desoxi-prostaglandin-fÿ2-derivat
DE3560258D1 (en) Norbornane and norbornene carboxylic acid amides and process for their preparation
ES543804A0 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo dialquilaminoalcoxi sustituido y de sus sa-les de adicion acidas y amonicas cuaternarias
NO873564D0 (no) Nye tyroninderivater.
DK72888D0 (da) Thionophosphonsyreestere, fremgangsmaader til deres fremstilling samt deres anvendelse som pesticider
ES2110454T3 (es) Compuestos de 6-oxo-azepinoindol, asi como procedimiento y productos intermedios para su preparacion y medicamentos que contienen estos compuestos.
ES2138052T3 (es) Derivados de ciclopropano y agentes antiviricos que los contienen.
DK61785A (da) 2-alkoxyaminosulfonylbenzensulfonylurinstofderivater, deres fremstilling og anvendelse som herbicider
ES8401761A1 (es) Un procedimiento para la preparacion de derivados de 1-(3,4,5-trimetoxicinamoil)-4-aminocarboniletil-piperazina sustituidos.
DE3172309D1 (en) Substituted 3,5-diamino-1,2,4-oxadiazoles and 3,5-diamino-1,2,4-thiadiazoles, their preparation and pharmaceutical compositions containing them
BE896098A (fr) Procede de modulation de la reponse immunitaire avec des dibenzocycloheptenylidenes
ES8702392A1 (es) Un procedimiento para preparar compuestos heterociclicos, en particular compuestos con un anillo de tiadiazinona
KR900018083A (ko) 에폭시숙신산 유도체
SE8800846L (sv) Optiskt aktiva oxo-isoindolinderivat
GB2071098B (en) Dibenzocycloheptenylidenes and antiinflammatory compositions
SE8303719D0 (sv) Novel eburnane oxime derivatives and process for preparing same

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8604950-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8604950-9

Format of ref document f/p: F